Daniel Nagore
R&d
Derio, PV, Spain
Derio, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Comparison between monotest and traditional batch-based ELISA assays for therapeutic drug monitoring of infliximab and adalimumab levels and anti-drug antibodies.
Journal: Clinical chemistry and laboratory medicine
Published: October 28, 2024
Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study.
Journal: Therapeutic advances in gastroenterology
Published: April 24, 2024
Uric acid and acute kidney injury in high-risk patients for developing acute kidney injury undergoing cardiac surgery: A prospective multicenter study.
Journal: Revista espanola de anestesiologia y reanimacion
Published: June 17, 2023
Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial.
Journal: Rheumatology and therapy
Published: May 28, 2021
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab.
Journal: Therapeutic advances in gastroenterology
Published: August 01, 2020
Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis.
Journal: Therapeutic advances in gastroenterology
Published: June 19, 2020
Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy.
Journal: The American journal of gastroenterology
Published: March 10, 2020
Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn's Disease.
Journal: Journal of Crohn's & colitis
Published: November 03, 2018
Optimal concentration range of ustekinumab in patients with plaque-type psoriasis.
Journal: Journal of the American Academy of Dermatology
Published: March 15, 2018
Proteomic pattern of implantative human endometrial fluid in in vitro fertilization cycles.
Journal: Archives of gynecology and obstetrics
Published: October 20, 2017
Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients.
Journal: Alimentary pharmacology & therapeutics
Published: July 21, 2017
Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease.
Journal: Inflammatory bowel diseases
Published: July 21, 2017
Last Updated: 09/26/2026